Delivery Order SPE2DB24D2011-SPE2DB24FBPPA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,337.32 firm fixed-price delivery order is for the supply of 4,567,476,935 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,909.53 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the delivery of Citalopram HBR 40 mg tablets in quantities of 500s to support military treatment programs and facilities. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,756,354 units of Citalopram HBR 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,997.07, has an ultimate completion date of August 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract award is not...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $20,622.55, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of 4,566,066,792 tablets of Citalopram HBR 40 mg. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price contract. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which is not...
- This federal contract award is for the delivery of 4,564,010,669 units of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,666.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a performance period through March 20, 2024. Amerisourcebergen Drug Corp has received numerous...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award is for the delivery of citalopram HBR 40 mg tablets in quantities of 500 to the Defense Logistics Agency (DLA). The contract, valued at $1,201.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,587.98 Firm Fixed Price Delivery Order is for the supply of 4,566,895 units of Citalopram HBr 40mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,613.37, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of February 15, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB24FBPPADelivery Order
This federal contract award is for the delivery of 4564415425 units of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,138.93 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/26/24 |